Integrated analysis of ATAC-seq and RNA-seq reveals ADSCP2 regulates oxidative phosphorylation pathway in hypertrophic scar fibroblasts

The primary effector cells involved in the formation of hypertrophic scars are fibroblasts. A potential peptide, ADSCP2 (adipose-derived stem cell peptide 2, the peptide fragment of ALCAM protein), derived from adipose-derived stem cell-conditioned medium, has been identified as having the potential...

Full description

Saved in:
Bibliographic Details
Main Authors: Qian Li, Zhe Quan, Ling Chen, Yiliang Yin, Xin Chen, Jingyun Li
Format: Article
Language:English
Published: PeerJ Inc. 2025-01-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/18902.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832570570320904192
author Qian Li
Zhe Quan
Ling Chen
Yiliang Yin
Xin Chen
Jingyun Li
author_facet Qian Li
Zhe Quan
Ling Chen
Yiliang Yin
Xin Chen
Jingyun Li
author_sort Qian Li
collection DOAJ
description The primary effector cells involved in the formation of hypertrophic scars are fibroblasts. A potential peptide, ADSCP2 (adipose-derived stem cell peptide 2, the peptide fragment of ALCAM protein), derived from adipose-derived stem cell-conditioned medium, has been identified as having the potential to mitigate hypertrophic scar formation by targeting pyruvate carboxylase. However, the underlying mechanisms remain incompletely understood. Whether ADSCP2 attenuates hypertrophic scar fibrosis at the transcription level remains unclear. Consequently, this study sought to elucidate the potential mechanism associated with ADSCP2 by examining genome-wide transcriptional alterations and changes in chromatin accessibility in fibroblasts. This was achieved through the integrated analysis of assay for transposase accessible chromatin using sequencing (ATAC-seq) and RNA sequencing (RNA-seq). In the ADSCP2 treatment group, ATAC-seq identified a total of 7,805 differential peaks associated with 3,176 genes. RNA-seq analysis revealed 345 upregulated and 399 downregulated transcripts in the same group. A combined Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of both downregulated genes and close-ACRs (accessible chromatin regions) genes within the ADSCP2 treatment group indicated regulation of the oxidative phosphorylation pathway (OXPHOS) by ADSCP2. The amalgamation of ATAC-seq and RNA-seq data elucidates that two OXPHOS associated genes, namely COX6B1 (cytochrome c oxidase subunit 6B1) and NDUFA1 (NADH dehydrogenase (ubiquinone) alpha subcomplex-1), demonstrate significant downregulation in the presence of ADSCP2. Further analysis using the integrative genomics viewer indicates that the promoter regions of both COX6B1 and NDUFA1 exhibit a higher degree of closure in the ADSCP2 treatment group. Quantitative PCR analysis demonstrated that ADSCP2 treatment resulted in a reduction of COX6B1 and NDUFA1 mRNA expression levels. Furthermore, cellular ATP and lactic acid concentrations were diminished in the ADSCP2-treated group. Collectively, these findings suggest potential avenues for future research into the therapeutic application of the peptide ADSCP2 in the treatment of hypertrophic scars.
format Article
id doaj-art-7aba609033cd48408c39abfa5f9a3142
institution Kabale University
issn 2167-8359
language English
publishDate 2025-01-01
publisher PeerJ Inc.
record_format Article
series PeerJ
spelling doaj-art-7aba609033cd48408c39abfa5f9a31422025-02-02T15:05:08ZengPeerJ Inc.PeerJ2167-83592025-01-0113e1890210.7717/peerj.18902Integrated analysis of ATAC-seq and RNA-seq reveals ADSCP2 regulates oxidative phosphorylation pathway in hypertrophic scar fibroblastsQian Li0Zhe Quan1Ling Chen2Yiliang Yin3Xin Chen4Jingyun Li5Department of Plastic & Cosmetic Surgery, Women’s Hospital of Nanjing Medical University (Nanjing Women and Children’s Healthcare Hospital), Nanjing, ChinaDepartment of Dermatology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Plastic & Cosmetic Surgery, Women’s Hospital of Nanjing Medical University (Nanjing Women and Children’s Healthcare Hospital), Nanjing, ChinaDepartment of Burns and Plastic Surgery, Yancheng No. 1 People’s Hospital, Affiliated Hospital of Medical School, Nanjing University, Yancheng, China. The First People’s Hospital of Yancheng, Yancheng, ChinaDepartment of Cardiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, ChinaNanjing Women and Children’s Healthcare Institute, Women’s Hospital of Nanjing Medical University (Nanjing Women and Children’s Healthcare Hospital), Nanjing, ChinaThe primary effector cells involved in the formation of hypertrophic scars are fibroblasts. A potential peptide, ADSCP2 (adipose-derived stem cell peptide 2, the peptide fragment of ALCAM protein), derived from adipose-derived stem cell-conditioned medium, has been identified as having the potential to mitigate hypertrophic scar formation by targeting pyruvate carboxylase. However, the underlying mechanisms remain incompletely understood. Whether ADSCP2 attenuates hypertrophic scar fibrosis at the transcription level remains unclear. Consequently, this study sought to elucidate the potential mechanism associated with ADSCP2 by examining genome-wide transcriptional alterations and changes in chromatin accessibility in fibroblasts. This was achieved through the integrated analysis of assay for transposase accessible chromatin using sequencing (ATAC-seq) and RNA sequencing (RNA-seq). In the ADSCP2 treatment group, ATAC-seq identified a total of 7,805 differential peaks associated with 3,176 genes. RNA-seq analysis revealed 345 upregulated and 399 downregulated transcripts in the same group. A combined Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of both downregulated genes and close-ACRs (accessible chromatin regions) genes within the ADSCP2 treatment group indicated regulation of the oxidative phosphorylation pathway (OXPHOS) by ADSCP2. The amalgamation of ATAC-seq and RNA-seq data elucidates that two OXPHOS associated genes, namely COX6B1 (cytochrome c oxidase subunit 6B1) and NDUFA1 (NADH dehydrogenase (ubiquinone) alpha subcomplex-1), demonstrate significant downregulation in the presence of ADSCP2. Further analysis using the integrative genomics viewer indicates that the promoter regions of both COX6B1 and NDUFA1 exhibit a higher degree of closure in the ADSCP2 treatment group. Quantitative PCR analysis demonstrated that ADSCP2 treatment resulted in a reduction of COX6B1 and NDUFA1 mRNA expression levels. Furthermore, cellular ATP and lactic acid concentrations were diminished in the ADSCP2-treated group. Collectively, these findings suggest potential avenues for future research into the therapeutic application of the peptide ADSCP2 in the treatment of hypertrophic scars.https://peerj.com/articles/18902.pdfHypertrophic scar fibroblastsADSCP2ATAC-seqRNA-seqOXPHOS
spellingShingle Qian Li
Zhe Quan
Ling Chen
Yiliang Yin
Xin Chen
Jingyun Li
Integrated analysis of ATAC-seq and RNA-seq reveals ADSCP2 regulates oxidative phosphorylation pathway in hypertrophic scar fibroblasts
PeerJ
Hypertrophic scar fibroblasts
ADSCP2
ATAC-seq
RNA-seq
OXPHOS
title Integrated analysis of ATAC-seq and RNA-seq reveals ADSCP2 regulates oxidative phosphorylation pathway in hypertrophic scar fibroblasts
title_full Integrated analysis of ATAC-seq and RNA-seq reveals ADSCP2 regulates oxidative phosphorylation pathway in hypertrophic scar fibroblasts
title_fullStr Integrated analysis of ATAC-seq and RNA-seq reveals ADSCP2 regulates oxidative phosphorylation pathway in hypertrophic scar fibroblasts
title_full_unstemmed Integrated analysis of ATAC-seq and RNA-seq reveals ADSCP2 regulates oxidative phosphorylation pathway in hypertrophic scar fibroblasts
title_short Integrated analysis of ATAC-seq and RNA-seq reveals ADSCP2 regulates oxidative phosphorylation pathway in hypertrophic scar fibroblasts
title_sort integrated analysis of atac seq and rna seq reveals adscp2 regulates oxidative phosphorylation pathway in hypertrophic scar fibroblasts
topic Hypertrophic scar fibroblasts
ADSCP2
ATAC-seq
RNA-seq
OXPHOS
url https://peerj.com/articles/18902.pdf
work_keys_str_mv AT qianli integratedanalysisofatacseqandrnaseqrevealsadscp2regulatesoxidativephosphorylationpathwayinhypertrophicscarfibroblasts
AT zhequan integratedanalysisofatacseqandrnaseqrevealsadscp2regulatesoxidativephosphorylationpathwayinhypertrophicscarfibroblasts
AT lingchen integratedanalysisofatacseqandrnaseqrevealsadscp2regulatesoxidativephosphorylationpathwayinhypertrophicscarfibroblasts
AT yiliangyin integratedanalysisofatacseqandrnaseqrevealsadscp2regulatesoxidativephosphorylationpathwayinhypertrophicscarfibroblasts
AT xinchen integratedanalysisofatacseqandrnaseqrevealsadscp2regulatesoxidativephosphorylationpathwayinhypertrophicscarfibroblasts
AT jingyunli integratedanalysisofatacseqandrnaseqrevealsadscp2regulatesoxidativephosphorylationpathwayinhypertrophicscarfibroblasts